07/07 RBC Capital Adjusts argenx SE ADR Price Target to $945 From $890, Maintains Outperform Rating MT
24/06 Argenx SE - Special Call
23/06 Argenx to Host Autoimmune Myositis R&D Webinar GL
22/06 BNP Paribas Boosts Argenx PT, Keeps Outperform Rating MT
22/06 Argenx Benefits From a UBS Note Zonebourse
22/06 BNP Paribas Initiates argenx at Outperform With $1,219 Price Target MT
17/06 ARGENX : Goldman Sachs reiterates its Buy rating ZD
10/06 Argenx SE Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 04:00 PM
08/06 William O'Neil Initiates argenx at Buy MT
03/06 KBC Securities Maintains Buy Rating on argenx Zonebourse
03/06 Argenx Unveils New Data on Vyvgart Zonebourse
03/06 Argenx Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit In Myositis And Sjogren?s Disease At EULAR 2026 CI
03/06 Argenx Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit in Myositis and Sjogren’s Disease at EULAR 2026 GL
28/05 ARGENX : Barclays reiterates its Buy rating ZD
28/05 Argenx to Host Myositis R&D Webinar on June 23, 2026 GL
27/05 Argenx Appears Confident of Rebound in Q2, RBC Says MT
27/05 ARGENX : RBC reaffirms its Buy rating ZD
27/05 Argenx to Present at Upcoming Investor Conferences GL
15/05 ARGENX : Deutsche Bank reaffirms its Buy rating ZD
13/05 Argenx SE Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 10:40 AM
12/05 ARGENX : Bernstein reiterates its Buy rating ZD
11/05 ARGENX : Goldman Sachs keeps its Buy rating ZD
11/05 ARGENX : Gets a Buy rating from Barclays ZD
11/05 Argenx Wins FDA Approval Expanding Vyvgart Use to All Serotypes of Generalized Myasthenia Gravis MT
11/05 Argenx Surges After Vyvgart Label Expansion Zonebourse
No results match your criteria